Theriva Biologics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.29

-0.03 (-9.35%)

As of May 16, 2:32 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +13,209.3% upside

Low Target $26.34

Average Target $38.73

High Target $46.19

Current Price $0.29

Current
$0.29

Target
$38.73

$26.34 $38.73 avg $46.19

Scenario Analysis

Bear Case

$26.34

8,951.5%

Low target

Base Case

$38.73

+13,209.3%

Avg target

Bull Case

$46.19

+15,772.9%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$0.86

-66.3% from high

52-Week Low

$0.16

+78.7% from low

Target vs 52W High

$38.73

+4,386.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%